At the Medicap Pharmacy® stores, we are dedicated to providing products and services to care for your family’s wellness. One of those services is health news you can trust. Use the filters to focus on the information that is important to you, then bookmark this page to make it a regular stop anytime you’re online.
The Future of Tuberculosis
The Centers for Disease Control and Prevention (CDC) is expecting the number of tuberculosis (TB) cases to increase in certain countries.
TB Turns Up in US
In 2015, the number of tuberculosis (TB) cases in the United States increased for the first time in 23 years, according to the Centers for Disease Control and Prevention (CDC).
Hundreds of Children Exposed to TB in El Paso Hospital
Tuberculosis (TB) is not as common in the US as it once was. Yet cases of the disease remain a concern, as was recently evidenced in West Texas.
Tracking Tuberculosis in US Kids
Tuberculosis is not a common disease in the US, but it does occur, even among children. So, who are those children?
Fifty Years Later, Work Remains to Curb Smoking
Fifty years ago, the US Surgeon General first warned of the dangerous effects of smoking. On the anniversary of that announcement, the current Surgeon General has released new data.
Drug Resistance Causes TB Worries
Tuberculosis might not be a huge concern in the US these days, but a new report on the state of tuberculosis around the globe showed that international progress still needs to be made.
Rx to Protect HIV Patients from TB
People with HIV have weakened immune systems, so they are more likely to catch harmful diseases like tuberculosis. However, new research suggests that a certain prevention therapy could significantly reduce that risk.
TB in the UK
Although tuberculosis (TB) is a preventable and curable disease, it still causes death and illness, especially in developing countries. And even developed countries are not out of the danger zone, particularly as immigration and travel help spread the disease.
FDA Permits Marketing of First US Test Labeled for Simultaneous Detection of Tuberculosis Bacteria and Resistance to the Antibiotic Rifampin
The US Food and Drug Administration today allowed marketing of the Xpert MTB/RIF Assay, the first FDA-reviewed test that can simultaneously detect bacteria that cause tuberculosis (TB) and determine if the bacteria contain genetic markers that makes them resistant to rifampin, an important antibiotic for the treatment of TB.
Australia Works to Resist Drug-Resistant TB
Tuberculosis is a disease spread between people through the air, and drug-resistant forms of the disease have put certain countries on alert. Right now, Australia is one of those countries.